tradingkey.logo
tradingkey.logo
Pesquisar

Envista Holdings Corp

NVST
Adicionar à lista de desejos
23.430USD
-0.200-0.85%
Fechamento 05/22, 16:00ETCotações atrasadas em 15 min
3.81BValor de mercado
56.94P/L TTM

Mais detalhes de Envista Holdings Corp Empresa

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Informações de Envista Holdings Corp

Código da empresaNVST
Nome da EmpresaEnvista Holdings Corp
Data de listagemSep 18, 2019
CEOKeel (Paul A)
Número de funcionários12300
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 18
Endereço200 S. Kraemer Blvd., Bldg. E
CidadeBREA
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal92821
Telefone17148175418
Sitehttps://envistaco.com/en
Código da empresaNVST
Data de listagemSep 18, 2019
CEOKeel (Paul A)

Executivos da empresa Envista Holdings Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
167.63K
+58.15%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
40.16K
-26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
40.15K
-26.03%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
34.23K
-30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
33.16K
-31.51%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
11.75K
-381.11%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
167.63K
+58.15%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
40.16K
-26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
40.15K
-26.03%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
34.23K
-30.53%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.28B
47.12%
All Other
1.24B
45.74%
China
194.40M
7.15%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
8.63%
Ariel Investments, LLC
7.36%
Dimensional Fund Advisors, L.P.
6.01%
Franklin Mutual Advisers, LLC
4.91%
Vanguard Portfolio Management, LLC
4.65%
Outro
68.45%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
8.63%
Ariel Investments, LLC
7.36%
Dimensional Fund Advisors, L.P.
6.01%
Franklin Mutual Advisers, LLC
4.91%
Vanguard Portfolio Management, LLC
4.65%
Outro
68.45%
Tipos de investidores
Investidores
Proporção
Investment Advisor
53.33%
Investment Advisor/Hedge Fund
45.04%
Hedge Fund
11.93%
Pension Fund
1.41%
Sovereign Wealth Fund
1.36%
Research Firm
1.31%
Bank and Trust
0.56%
Individual Investor
0.48%
Private Equity
0.36%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
711
203.45M
125.03%
-3.29M
2025Q4
698
191.18M
116.72%
-29.60M
2025Q3
713
196.49M
119.50%
-31.47M
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
14.04M
8.57%
-276.49K
-1.93%
Dec 31, 2025
Ariel Investments, LLC
11.97M
7.3%
-33.66K
-0.28%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
9.63M
5.88%
+90.59K
+0.95%
Dec 31, 2025
Franklin Mutual Advisers, LLC
7.99M
4.87%
-705.06K
-8.11%
Dec 31, 2025
Atlanta Capital Management Company, L.L.C.
7.38M
4.5%
-1.29M
-14.85%
Dec 31, 2025
Victory Capital Management Inc.
6.06M
3.7%
+146.75K
+2.48%
Dec 31, 2025
AllianceBernstein L.P.
6.04M
3.68%
-62.95K
-1.03%
Dec 31, 2025
Gates Capital Management, Inc.
5.81M
3.54%
-414.85K
-6.67%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
State Street SPDR S&P Health Care Equipment ETF
1.75%
Schwab Ariel Opportunities ETF
1.51%
Pacer US Export Leaders ETF
0.88%
Distillate Small/Mid Cash Flow ETF
0.58%
Royce Quant Small-Cap Quality Value ETF
0.5%
Harbor Long-Short Equity ETF
0.45%
First Trust Health Care Alphadex Fund
0.41%
iShares U.S. Medical Devices ETF
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
DFA Dimensional US Small Cap Value ETF
0.27%
Ver Mais
State Street SPDR S&P Health Care Equipment ETF
Proporção1.75%
Schwab Ariel Opportunities ETF
Proporção1.51%
Pacer US Export Leaders ETF
Proporção0.88%
Distillate Small/Mid Cash Flow ETF
Proporção0.58%
Royce Quant Small-Cap Quality Value ETF
Proporção0.5%
Harbor Long-Short Equity ETF
Proporção0.45%
First Trust Health Care Alphadex Fund
Proporção0.41%
iShares U.S. Medical Devices ETF
Proporção0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporção0.3%
DFA Dimensional US Small Cap Value ETF
Proporção0.27%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI